High sensitivity,specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women

Abstract

The Connective Tissue Disease Screening Questionnaire (CSQ), developed to screen populations for SLE and other CTDs, has been validated in a predominantly Caucasian population with hospital-based controls. We aimed to test the performance characteristics of the CSQ in an urban, predominantly African-American population. The CSQ was administered by interview to women recruited for a study of environmental risk factors and SLE, including 99 cases with SLE validated by medical record review and 202 healthy controls recruited from the community. Overall, 88% of subjects had African heritage, 6% were Hispanic and 4% were non-Hispanic Caucasian. Controls were more likely to report African heritage than cases (91% versus 82%, P < 0.001). Sensitivity for detecting SLE was 88% and specificity was 91%. In this study, where the prevalence of SLE was 33%, predictive value of a positive CSQ was 82% and predictive value of a negative CSQ was 94%. The CSQ has slightly lower sensitivity but greater specificity for SLE in an urban, predominantly African-American population with community-based controls compared with a Caucasian population with hospital-based controls. These results suggest that the CSQ has adequate sensitivity and specificity and could be used in population studies to screen African-American women for SLE.

Keywords

African-American connective tissue disease lupus screening sensitivity

Get full access to this article

View all access options for this article.

References

Siegel M , Holley HL , Lee SL. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965 . Arthritis Rheum 1970; 13: 802-811 .

Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women . Arch Intern Med 1974; 134: 1027-1035 .

Hopkinson ND , Doherty M , Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients . Ann Rheum Dis 1994; 53: 675-680 .

Johnson AE , Gordon C , Palmer RG , Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth . Arthritis Rheum 1995; 38: 551-558 .

McCarty DJ , Manzi S , Medsger TA, Jr , Ramsey-Goldman R , LaPorte RE , Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences . Arthritis Rheum 1995; 38: 1260-1270 .

Ward MM , Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences . Arch Intern Med 1990; 150: 849-853 .

Hopkinson ND , Jenkinson C , Muir KR , Doherty M , Powell RJ. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus . Ann Rheum Dis 2000; 59: 116-119 .

Alarcon GS , Friedman AW , Straaton KV et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture . Lupus 1999; 8: 197-209 .

Isenberg DA , Garton M , Reichlin MW , Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients . Br J Rheumatol 1997; 36: 229-233 .

10.

Cooper GS , Parks CG , Treadwell EL et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States . Lupus 2002; 11: 161-167 .

11.

Liang MH , Meenan RF , Cathcart ES , Schur PH. A screening strategy for population studies in systemic lupus erythematosus. Series design . Arthritis Rheum 1980; 23: 153-157 .

12.

Hochberg MC , Schmidt MC , Funk KL , Sutton JD , Stevens MB. Validity and yield of a two-stage screening procedure for systemic lupus erythematosus . Clin Exp Rheumatol 1983; 1: 67-71 .

13.

Karlson EW , Sanchez-Guerrero J , Wright EA et al. A connective tissue disease screening questionnaire for population studies . Ann Epidemiol 1995; 5: 297-302 .

14.

Johnson AE , Gordon C , Hobbs FD , Bacon PA. Undiagnosed systemic lupus erythematosus in the community . Lancet 1996; 347: 367-369 .

15.

Geva E , Lerner-Geva L , Burke M , Vardinon N , Lessing JB , Amit A. Undiagnosed systemic lupus erythematosus in a cohort of infertile women . Am J Reprod Immunol 2004; 51: 336-340 .

16.

Chou CT , Lee FT , Schumacher HR. Modification of a screening technique to evaluate systemic lupus erythematosus in a Chinese population in Taiwan . J Rheumatol 1986; 13: 806-809 .

17.

Lee HS , Oh KT , Kim TH , Jung S , Yoo DH , Bae SC. A Korean rheumatic diseases screening questionnaire . J Korean Med Sci 2003; 18: 171-178 .

18.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

19.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

20.

Sanchez-Guerrero J , Colditz GA , Karlson EW , Hunter DJ , Speizer FE , Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms . N Engl J Med 1995; 332: 1666-1670 .

21.

Karlson EW , Mandl LA , Aweh GN , Grodstein F. Coffee consumption and risk of rheumatoid arthritis . Arthritis Rheum 2003; 48: 3055-3060 .

22.

McAlindon TE , Formica M , Palmer JR , Lafyatis R , Rosenberg L. Assessment of strategies for identifying diagnosed cases of systemic lupus erythematosus through self-report . Lupus 2003; 12: 754-759 .